Biocomposites to present data on STIMULAN® at American Academy of Orthopaedic Surgeons Annual Meeting
STIMULAN is the only calcium matrix antibiotic carrier approved for use in bone and soft tissue in the EU, UK, Canada, and Saudi Arabia
Keele, UK, 15 March 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce that Professor Paul Stoodley will be presenting the results of his in vitro study into the effectiveness of different dual combination antibiotics in killing antibiotic resistant and tolerant persister cells in lawn biofilms of Staphylococcus aureus and Pseudomonas aeruginosa at the American Academy of Orthopaedic Surgeons Annual Meeting (AAOS), being held in Chicago, 22-26 March 2022.
